XRAY
$8.87+5.34%
DENTSPLY SIRONA Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMNasdaq Composite · 0.007% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
XRAY financial statements
The full income statement, balance sheet, and cash-flow statement for DENTSPLY SIRONA Inc. (XRAY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 202.7M2024-09 198.8M2024-12 199.0M2025-03 199.3M2025-06 199.5M2025-09 199.6M2025-12 199.7M2026-03 200.3M2026-06 199.4M-1.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.68B-3.0% | 3.79B-4.3% | 3.96B+1.1% | 3.92B-7.3% | 4.23B+26.7% | |
| 1.84B-6.0% | 1.96B-6.1% | 2.09B-1.9% | 2.13B-9.4% | 2.35B+41.7% | ||
| Cost of revenue | 1.84B+0.3% | 1.83B-2.3% | 1.88B+4.7% | 1.79B-4.7% | 1.88B+11.9% | |
| Research & development | 150M-9.1% | 165M-10.3% | 184M+5.7% | 174M+1.8% | 171M+39.0% | |
| Selling, general & administrative | 1.44B-10.4% | 1.60B-0.5% | 1.61B+1.5% | 1.59B+2.5% | 1.55B+19.1% | |
| Restructuring | 24.0M-54.7% | 53.0M-20.9% | 67.0M+378.6% | 14.0M-17.6% | 17.0M | |
| Amortization of intangibles | 211M-2.3% | 216M+2.4% | 211M+1.0% | 209M-5.9% | 222M+15.6% | |
| Operating income | -422M+52.0% | -879M-934.1% | -85.0M+90.9% | -937M-254.1% | 608M+20366.7% | |
| Interest expense | 88.0M+27.5% | 69.0M-14.8% | 81.0M+24.6% | 65.0M+6.6% | 61.0M+27.1% | |
| Other non-operating income | 24.0M+100.0% | 12.0M+233.3% | -9.00M+83.0% | -53.0M-2550.0% | -2.00M-100.0% | |
| Equity-method income | 0.00 | 0.00+100.0% | -4.00M+88.9% | -36.0M-260.0% | -10.0M | |
| Pre-tax income | -486M+48.1% | -936M-434.9% | -175M+83.4% | -1.05B-293.6% | 545M+1008.3% | |
| Income tax | 112M+530.8% | -26.0M+39.5% | -43.0M+59.0% | -105M-178.4% | 134M+482.6% | |
| -598M+34.3% | -910M-589.4% | -132M+86.1% | -950M-331.1% | 411M+663.0% | ||
| Net income to non-controlling interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -$3.00+33.0% | -$4.48-622.6% | -$0.62+85.9% | -$4.41-335.8% | $1.87+666.7% | ||
| EPS (basic) | -$3.00+33.0% | -$4.48-622.6% | -$0.62+85.9% | -$4.41-334.6% | $1.88+669.7% | |
| Weighted-avg shares (basic) | 199M-1.9% | 203M-4.2% | 212M-1.6% | 216M-1.3% | 218M-0.4% | |
| Weighted-avg shares (diluted) | 199M-1.9% | 203M-4.2% | 212M-1.6% | 216M-2.1% | 220M+0.5% | |
| Dividends per share | $0.64+0.0% | $0.64+14.3% | $0.56+12.0% | $0.50+16.3% | $0.43+7.5% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.02B+15.9% | 1.75B-11.5% | 1.97B+4.2% | 1.89B+2.2% | 1.85B+3.0% | ||
| Cash & equivalents | 326M+19.9% | 272M-18.6% | 334M-8.5% | 365M+7.7% | 339M-22.6% | |
| Inventory | 642M+13.8% | 564M-9.6% | 624M-0.5% | 627M+21.7% | 515M+8.2% | |
| Prepaid expenses | 367M+3.7% | 354M+10.6% | 320M+19.0% | 269M+8.5% | 248M+14.3% | |
| Other current assets | 150M-2.0% | 153M+35.4% | 113M+28.4% | 88.0M+4.8% | 84.0M+25.4% | |
| 5.43B-5.6% | 5.75B-21.9% | 7.37B-3.6% | 7.64B-17.3% | 9.24B-1.2% | ||
| Property, plant & equipment | — | — | 800M+5.1% | 761M-1.6% | 773M-2.3% | |
| Operating lease right-of-use | 139M+2.2% | 136M-23.6% | 178M-11.0% | 200M+1.0% | 198M+12.5% | |
| Goodwill | 1.15B-28.1% | 1.60B-34.5% | 2.44B-9.3% | 2.69B-32.4% | 3.98B-0.3% | |
| Intangible assets | 974M-19.3% | 1.21B-29.2% | 1.71B-10.4% | 1.90B-17.9% | 2.32B-7.4% | |
| Other non-current assets | 284M-5.6% | 301M+9.1% | 276M+39.4% | 198M+63.6% | 121M+27.4% | |
| 1.34B-15.5% | 1.59B+11.5% | 1.43B+21.8% | 1.17B-7.2% | 1.26B-8.1% | ||
| Accounts payable | 300M+24.5% | 241M-21.0% | 305M+9.3% | 279M+6.5% | 262M-13.2% | |
| Accrued liabilities | 700M-7.2% | 754M+0.7% | 749M+3.0% | 727M-4.3% | 760M+6.7% | |
| Deferred revenue | 74.0M-22.1% | 95.0M+4.4% | 91.0M+8.3% | 84.0M+23.5% | 68.0M+28.3% | |
| Short-term & current debt | 228M+78.1% | 128M+66.2% | 77.0M+7600.0% | 1.00M+0.0% | 1.00M-99.7% | |
| Current lease liability | 47.0M+2.2% | 46.0M-17.9% | 56.0M+3.7% | 54.0M+8.0% | 50.0M+4.2% | |
| Finance lease liability (current) | — | — | 0.00-100.0% | 1.00M+0.0% | 1.00M | |
| 4.09B+7.3% | 3.81B-6.5% | 4.08B+6.4% | 3.83B-9.7% | 4.24B-3.9% | ||
| Long-term debt | 2.02B+27.0% | 1.59B-11.7% | 1.80B-1.6% | 1.83B-4.5% | 1.91B-3.3% | |
| Deferred revenue (non-current) | 33.0M-32.7% | 49.0M-14.0% | 57.0M+111.1% | 27.0M | — | |
| Non-current lease liability | 93.0M+2.2% | 91.0M-27.2% | 125M-16.1% | 149M+0.0% | 149M+14.6% | |
| Operating lease liability (total) | 140M+2.2% | 137M-24.3% | 181M-10.8% | 203M+2.0% | 199M+11.8% | |
| Finance lease liability (total) | — | — | 1.00M-50.0% | 2.00M+0.0% | 2.00M+100.0% | |
| Finance lease liability | 0.00 | 0.00-100.0% | 1.00M+0.0% | 1.00M+0.0% | 1.00M+0.0% | |
| Deferred tax liabilities | 94.0M-27.1% | 129M-43.4% | 228M-20.6% | 287M-26.6% | 391M+2.6% | |
| Other non-current liabilities | 544M+31.1% | 415M-17.3% | 502M+25.8% | 399M-24.4% | 528M-4.7% | |
| 1.34B-31.1% | 1.94B-41.0% | 3.29B-13.6% | 3.81B-23.7% | 5.00B+1.3% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | |
| Additional paid-in capital | 6.64B+0.1% | 6.64B-0.0% | 6.64B+0.2% | 6.63B+0.3% | 6.61B+0.0% | |
| Retained earnings | -1.56B-87.3% | -835M-507.3% | 205M-55.0% | 456M-69.9% | 1.51B+26.4% | |
| Treasury stock | 3.10B-1.0% | 3.14B+7.3% | 2.92B+10.3% | 2.65B+4.5% | 2.54B+5.2% | |
| Accumulated other comprehensive income | -639M+12.5% | -730M-14.8% | -636M-1.3% | -628M-6.1% | -592M-27.6% | |
| Non-controlling interest | 1.00M+0.0% | 1.00M+0.0% | 1.00M+0.0% | 1.00M+0.0% | 1.00M-66.7% | |
| Total equity incl. non-controlling | 1.34B-31.0% | 1.94B-41.0% | 3.29B-13.6% | 3.81B-23.7% | 5.00B+1.3% | |
| Total liabilities & equity | 5.43B-5.6% | 5.75B-21.9% | 7.37B-3.6% | 7.64B-17.3% | 9.24B-1.2% | |
| Common shares issued | 265M+0.0% | 265M+0.0% | 265M+0.0% | 265M+0.0% | 265M+0.0% | |
| Common shares outstanding | 200M+0.4% | 199M-4.1% | 207M-3.7% | 215M-1.0% | 217M-0.6% | |
| Shares outstanding (cover) | 200M+0.4% | 199M-4.0% | 207M-3.7% | 215M-1.0% | 218M-0.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 235M-49.0% | 461M+22.3% | 377M-27.1% | 517M-21.3% | 657M+1.2% | ||
| Depreciation & amortization | 352M+0.9% | 349M+1.7% | 343M+4.6% | 328M-5.5% | 347M+3.9% | |
| Intangible amortization | 211M-2.3% | 216M+2.4% | 211M+1.0% | 209M-5.9% | 222M+15.6% | |
| Share-based compensation | 33.0M-15.4% | 39.0M-15.2% | 46.0M-22.0% | 59.0M+22.9% | 48.0M+2.1% | |
| Deferred income taxes | 30.0M+122.1% | -136M-4.6% | -130M+43.0% | -228M-812.0% | -25.0M+59.7% | |
| Change in inventory | 17.0M+200.0% | -17.0M-183.3% | -6.00M-104.3% | 141M+120.3% | 64.0M+152.0% | |
| Change in payables | 11.0M+136.7% | -30.0M-314.3% | 14.0M-53.3% | 30.0M+161.2% | -49.0M-75.0% | |
| -132M+33.0% | -197M-121.3% | -89.0M+35.5% | -138M+61.5% | -358M+67.6% | ||
| Capital expenditure | 131M-27.2% | 180M+20.8% | 149M+0.0% | 149M+4.9% | 142M+63.2% | |
| Free cash flow | 104M-63.0% | 281M+23.2% | 228M-38.0% | 368M-28.5% | 515M-8.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 248M-77.0% | |
| Proceeds from sale of PP&E | — | — | 7.00M | 0.00 | 0.00-100.0% | |
| Other investing activities | -3.00M-150.0% | 6.00M+175.0% | -8.00M-500.0% | 2.00M+200.0% | -2.00M | |
| -80.0M+73.5% | -302M+1.6% | -307M+6.7% | -329M+13.2% | -379M-179.6% | ||
| Long-term debt issued | 553M+55200.0% | 1.00M | 0.00-100.0% | 6.00M-62.5% | 16.0M | |
| Long-term debt repaid | 147M+67.0% | 88.0M+1157.1% | 7.00M+250.0% | 2.00M-99.3% | 297M-57.6% | |
| Net short-term debt | — | 177M+40.5% | 126M+296.9% | -64.0M-135.8% | 179M+8850.0% | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00-100.0% | 250M-16.7% | 300M+100.0% | 150M-25.0% | 200M+42.9% | |
| Dividends paid | 128M+1.6% | 126M+8.6% | 116M+11.5% | 104M+13.0% | 92.0M+4.5% | |
| Other financing activities | -6.00M+62.5% | -16.0M-60.0% | -10.0M+33.3% | -15.0M+58.3% | -36.0M-38.5% | |
| FX effect on cash | 31.0M+229.2% | -24.0M-100.0% | -12.0M+50.0% | -24.0M-26.3% | -19.0M-235.7% | |
| Net change in cash | 54.0M+187.1% | -62.0M-100.0% | -31.0M-219.2% | 26.0M+126.3% | -99.0M-400.0% | |
| Interest paid | 66.0M-27.5% | 91.0M-6.2% | 97.0M+38.6% | 70.0M+9.4% | 64.0M+42.2% | |
| Income taxes paid | 71.0M-4.1% | 74.0M-58.2% | 177M+45.1% | 122M-17.6% | 148M+80.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 2.28B-39.5% | 3.78B-49.9% | 7.54B+10.2% | 6.84B-43.6% | 12.1B+5.8% | |
| P/E | — | — | — | — | 29.5× | |
| P/S | 0.6×-37.7% | 1.0×-48.0% | 1.9×+13.2% | 1.7×-41.0% | 2.9×-16.5% | |
| P/B | 1.7×-12.3% | 1.9×-12.9% | 2.2×+18.0% | 1.9×-22.0% | 2.4×+4.5% | |
| P/FCF | 22.0×+63.3% | 13.4×-61.1% | 34.6×+9.7% | 31.5×+33.8% | 23.6×+15.5% | |
| Earnings yield | — | — | — | — | 3.4% | |
| FCF yield | 4.6%-38.8% | 7.4%+157.3% | 2.9%-8.8% | 3.2%-25.3% | 4.2%-13.4% | |
| Dividend yield | 5.6%+66.1% | 3.4%+114.3% | 1.6%+0.2% | 1.6%+103.7% | 0.77%+0.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K/A | 10-K/A |
About this data
Source: XRAY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all XRAY filings on SEC EDGAR → Not investment advice.